Skip to main content
Equibles
AVTX logo

AVTX · Avalo Therapeutics, Inc. · Investor Relations

Track AVTX — free

Use AVTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AVTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.27 -0.74 (-6.16%) At close · Oct 16
Russell 2000 member Rebalance outlook locked
Market Cap
$612.72M
Shares
53.63M
Volume · Oct 16 971.12K Avg daily vol (3M) 937.19K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-10-03 EADV Congress 2026 Event
2026-09-24 Stifel 2026 Virtual Immunology and Inflammation Forum Webcast
2026-09-16 H.C. Wainwright 28th Annual Global Investment Conference Conference
2026-09-16 Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-09-10 Cantor Global Healthcare Conference 2026 Conference
2026-07-29 BTIG Virtual Biotechnology Conference 2026 Conference
2026-07-15 Leerink Partners Therapeutics Forum Event
2026-06-02 2026 Annual Meeting of Stockholders Shareholder meeting
2026-03-10 Leerink Partners Global Healthcare Conference Conference
2026-03-03 TD Cowen Annual Healthcare Conference Conference

Source: https://ir.avalotx.com/

Key facts CIK 1534120 CUSIP 05338F306 13F (30d) 8 filings 8 filers Visit website Investor relations